These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30335598)

  • 21. The role of ESCO2, SALL4 and TBX5 genes in the susceptibility to thalidomide teratogenesis.
    Gomes JDA; Kowalski TW; Fraga LR; Macedo GS; Sanseverino MTV; Schuler-Faccini L; Vianna FSL
    Sci Rep; 2019 Aug; 9(1):11413. PubMed ID: 31388035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of thalidomide use in birth defects in Brazil.
    Sales Luiz Vianna F; Kowalski TW; Fraga LR; Sanseverino MT; Schuler-Faccini L
    Eur J Med Genet; 2017 Jan; 60(1):12-15. PubMed ID: 27638330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalidomide and neurotrophism.
    Soper JR; Bonar SF; O'Sullivan DJ; McCredie J; Willert HG
    Skeletal Radiol; 2019 Apr; 48(4):517-525. PubMed ID: 30341712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thalidomide--a dreaded drug with new indications].
    Waage A; Seidel C
    Tidsskr Nor Laegeforen; 2001 Oct; 121(25):2954-7. PubMed ID: 11715779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptosis induction by thalidomide: critical for limb teratogenicity but therapeutic potential in idiopathic pulmonary fibrosis?
    Knobloch J; Jungck D; Koch A
    Curr Mol Pharmacol; 2011 Jan; 4(1):26-61. PubMed ID: 20958261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thalidomide induces limb deformities by perturbing the Bmp/Dkk1/Wnt signaling pathway.
    Knobloch J; Shaughnessy JD; Rüther U
    FASEB J; 2007 May; 21(7):1410-21. PubMed ID: 17283219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Teratogen update: clinical aspects of thalidomide embryopathy--a continuing preoccupation.
    Newman CG
    Teratology; 1985 Aug; 32(1):133-44. PubMed ID: 4035587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thalidomide Inhibits Human iPSC Mesendoderm Differentiation by Modulating CRBN-dependent Degradation of SALL4.
    Belair DG; Lu G; Waller LE; Gustin JA; Collins ND; Kolaja KL
    Sci Rep; 2020 Feb; 10(1):2864. PubMed ID: 32071327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thalidomide, a current teratogen in South America.
    Castilla EE; Ashton-Prolla P; Barreda-Mejia E; Brunoni D; Cavalcanti DP; Correa-Neto J; Delgadillo JL; Dutra MG; Felix T; Giraldo A; Juarez N; Lopez-Camelo JS; Nazer J; Orioli IM; Paz JE; Pessoto MA; Pina-Neto JM; Quadrelli R; Rittler M; Rueda S; Saltos M; Sánchez O; Schüler L
    Teratology; 1996 Dec; 54(6):273-7. PubMed ID: 9098920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The temporal dynamics of vertebrate limb development, teratogenesis and evolution.
    Zeller R
    Curr Opin Genet Dev; 2010 Aug; 20(4):384-90. PubMed ID: 20537528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses.
    Miller MT; Strömland K
    Teratology; 1999 Nov; 60(5):306-21. PubMed ID: 10525208
    [No Abstract]   [Full Text] [Related]  

  • 32. Congenital fusion of bones: radiology, embryology and pathogenesis.
    McCredie J
    Clin Radiol; 1975 Jan; 26(1):47-51. PubMed ID: 1122695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of the treatment of thalidomide children with limb defeciency in Great Britain.
    Fletcher I
    Clin Orthop Relat Res; 1980 May; (148):18-25. PubMed ID: 6991189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in the molecular mechanism of thalidomide teratogenicity.
    Gao S; Wang S; Fan R; Hu J
    Biomed Pharmacother; 2020 Jul; 127():110114. PubMed ID: 32304852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity.
    Parman T; Wiley MJ; Wells PG
    Nat Med; 1999 May; 5(5):582-5. PubMed ID: 10229238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The return of thalidomide: are birth defects surveillance systems ready?
    Yang Q; Khoury MJ; James LM; Olney RS; Paulozzi LJ; Erickson JD
    Am J Med Genet; 1997 Dec; 73(3):251-8. PubMed ID: 9415679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thalidomide (Contergan) induced limb deficiency in Hungary?].
    Gidai J; Bács E; Czeizel E
    Orv Hetil; 2009 Jun; 150(25):1179-81. PubMed ID: 19497840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sclerotome subtraction: a radiologic interpretation of reduction deformities of the limbs.
    McCredie J
    Birth Defects Orig Artic Ser; 1977; 13(3D):65-77. PubMed ID: 922142
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacoepidemiology and thalidomide embryopathy surveillance in Brazil.
    Sales Luiz Vianna F; de Oliveira MZ; Sanseverino MT; Morelo EF; de Lyra Rabello Neto D; Lopez-Camelo J; Camey SA; Schuler-Faccini L
    Reprod Toxicol; 2015 Jun; 53():63-7. PubMed ID: 25828060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Habilitation of patients with congenital malformations associated with thalidomide: surgery of limb defects.
    HALL JE
    Can Med Assoc J; 1963 May; 88(19):964-72. PubMed ID: 13952105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.